课题基金 / 基金详情

项目摘要

项目成果

ARIANNE L THEISS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): Prohibitin is a highly conserved protein that has pleiotropic functions depending on the cell and tissue type in which it is expressed. Little is known regarding the expression and function of prohibitin in the intestine. During my postdoctoral fellowship I demonstrated that 1) prohibitin is expressed by native human colonic epithelia as well as model intestinal epithelial cells, 2) in resting intestinal epithelial cells, prohibitin localizes to the mitochondria and protects against oxidative stress, 3) prohibitin is downregulated during oxidant stress, during active human inflammatory bowel disease (IBD) and experimental colitis, and 4) prohibitin transgenic mice are protected from DSS- and Salmonella typhimurium-induced colitis and oxidative stress. In assessing the mechanism by which prohibitin modulates inflammation, our preliminary data demonstrate that prohibitin is a potent activator of Nrf2, a master transcriptional regulator that activates a battery of anti-oxidant genes. In addition, our recent in vitro data demonstrate that prohibitin inhibits TNF(-induced NF-(B activation and barrier dysfunction. Based on these data, the central hypothesis of this proposal is that prohibitin functions as an epithelial defense against oxidative stress and inflammation-induced barrier dysfunction and decreased levels of prohibitin in IBD contribute to tissue injury and inflammation. The overall objective of the proposal is to determine the mechanism underlying the protective role of prohibitin in colitis. Our interrelated yet independently achievable aims based on our hypothesis and supported by preliminary data are i) to determine the role and mechanism by which prohibitin modulates Nrf2, ii) to address the mechanism of prohibitin in inhibiting NF-(B signaling and its downstream effects, and iii) to determine the in vivo mechanism by which prohibitin ameliorates colitis Together, these studies will elucidate the function and mechanism of action of prohibitin as an activator of anti-oxidants and as an anti-inflammatory molecule in intestinal epithelial cells. The training in protein biochemistry and electrophysiology the candidate will learn from executing the proposed studies will improve potential for transition to an independent IBD researcher. PUBLIC HEALTH RELEVANCE: This study proposes to define the function and mechanism of prohibitin in protecting against oxidative stress, NF-(B activation and barrier dysfunction, which are hallmarks of intestinal inflammation. These studies are designed to provide evidence for prohibitin as a potential therapeutic target to prevent the consequences of intestinal inflammation.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0031231
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Kathiria AS, Butcher LD, Feagins LA, Souza RF, Boland CR, Theiss AL]
通讯作者: Theiss AL
DOI: 10.4161/jkst.24150
发表时间: 2013-07-01
期刊: JAK-STAT
影响因子: --
作者: [Theiss AL]
通讯作者: Theiss AL
DOI: 10.1016/j.cellsig.2014.06.006
发表时间: 2014-10
期刊: Cellular signalling
影响因子: 4.8
作者: [Han J, Yu C, Souza RF, Theiss AL]
通讯作者: Theiss AL
Stat3: friend or foe in colitis and colitis-associated cancer?
Stat3:结肠炎和结肠炎相关癌症的朋友或敌人?
DOI: 10.1097/mib.0000000000000180
发表时间: 2014-12
期刊: Inflammatory bowel diseases
影响因子: 4.9
作者: [Han J, Theiss AL]
通讯作者: Theiss AL
Adipose Tissue Extracellular Vesicles in Colorectal Tumorigenesis
Adipose Tissue Extracellular Vesicles in Colorectal Tumorigenesis
Mitochondrial Dysfunction and Mitophagy in Ileitis
  • 批准号:
    9982322
  • 项目类别:
  • 资助金额:
    $35.25万
  • 财政年份:
    2019
  • 负责人:
    ARIANNE L THEISS
  • 依托单位:
Diversity Supplement to R01 Mitochondrial Dysfunction and Mitophagy in Ileitis
  • 批准号:
    10443329
  • 项目类别:
  • 资助金额:
    $4.65万
  • 财政年份:
    2019
  • 负责人:
    ARIANNE L THEISS
  • 依托单位:
海外基金